<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2022.868152</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypic and Genotypic Characteristics of a Tigecycline-Resistant <italic>Acinetobacter pittii</italic> Isolate Carrying <italic>bla</italic><sub>NDM&#x2013;1</sub> and the Novel <italic>bla</italic><sub>OXA</sub> Allelic Variant <italic>bla</italic><sub>OXA&#x2013;1045</sub></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ding</surname> <given-names>Zixuan</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1645863/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Zhaoyinqian</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1514276/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Yuanqing</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1761669/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hao</surname> <given-names>Jingchen</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1104578/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Tingting</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1761742/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Yao</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1761953/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zeng</surname> <given-names>Zhangrui</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1762048/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Liu</surname> <given-names>Jinbo</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/964094/overview"/>
</contrib>
</contrib-group>
<aff><institution>Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Eun-Jeong Yoon, Korea National Institute of Health, South Korea</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Siqiang Niu, The First Affiliated Hospital of Chongqing Medical University, China; Somdatta Chatterjee, IGeneX Inc., United States</p></fn>
<corresp id="c001">&#x002A;Correspondence: Jinbo Liu, <email>Liulab2019@163.com</email></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>868152</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Ding, Li, Zhao, Hao, Li, Liu, Zeng and Liu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Ding, Li, Zhao, Hao, Li, Liu, Zeng and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>A tigecycline-resistant <italic>Acinetobacter pittii</italic> clinical strain from pleural fluid carrying a <italic>bla</italic><sub>NDM&#x2013;1</sub> gene and a novel <italic>bla</italic><sub>OXA</sub> gene, <italic>bla</italic><sub>OXA&#x2013;1045</sub>, was isolated and characterized. The AP2044 strain acquired two copies of the <italic>bla</italic><sub>NDM&#x2013;1</sub> gene and six antibiotic resistance genes (ARGs) from other pathogens. According to the whole-genome investigation, the GC ratios of ARGs (50&#x2013;60%) were greater than those of the chromosomal backbone (39.46%), indicating that ARGs were horizontally transferred. OXA-1045 belonged to the OXA-213 subfamily and the amino acid sequence of OXA-1045 showed 89% similarity to the amino acid sequences of OXA-213. Then, <italic>bla</italic><sub>OXA&#x2013;1045</sub> and <italic>bla</italic><sub>OXA&#x2013;213</sub> were cloned and the minimum inhibitory concentrations (MICs) of &#x03B2;-lactams in the transformants were determined using the broth microdilution method. OXA-1045 was able to confer a reduced susceptibility to piperacillin and piperacillin-tazobactam compared to OXA-213. AP2044 strain exhibited low pathogenicity in <italic>Galleria mellonella</italic> infection models. The observation of condensed biofilm using the crystal violet staining method and scanning electron microscopy (SEM) suggested that the AP2044 strain was a weak biofilm producer. Quantitative reverse transcription-PCR (qRT-PCR) was used to detect the expression of resistance-nodulation-cell division (RND) efflux pump-related genes. The transcription level of <italic>adeB</italic> and <italic>adeJ</italic> genes increased significantly and was correlated with tigecycline resistance. Therefore, our genomic and phenotypic investigations revealed that the AP2044 strain had significant genome plasticity and natural transformation potential, and the emergence of antibiotic resistance in these unusual bacteria should be a concern for future investigations.</p>
</abstract>
<kwd-group>
<kwd><italic>Acinetobacter pittii</italic></kwd>
<kwd>tigecycline resistance</kwd>
<kwd>carbapenem resistance</kwd>
<kwd>OXA-1045</kwd>
<kwd>whole genome sequencing</kwd>
</kwd-group>
<contract-sponsor id="cn001">Sichuan Province Science and Technology Support Program<named-content content-type="fundref-id">10.13039/100012542</named-content></contract-sponsor><contract-sponsor id="cn002">Sichuan Province Science and Technology Support Program<named-content content-type="fundref-id">10.13039/100012542</named-content></contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="69"/>
<page-count count="12"/>
<word-count count="7638"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p><italic>Acinetobacter</italic> spp. has been a global threat in the healthcare setting since they rapidly develop resistance to antibiotics. Among these species, <italic>Acinetobacter baumannii</italic>, <italic>Acinetobacter nosocomialis</italic>, and <italic>Acinetobacter pittii</italic> are the most common isolates in hospitals and are associated with nosocomial infections (<xref ref-type="bibr" rid="B62">Weber et al., 2015</xref>; <xref ref-type="bibr" rid="B4">Almasaudi, 2018</xref>). <italic>A. pittii</italic>, previously known as <italic>Acinetobacter</italic> genomic species three, is the most frequently isolated from nosocomial infections among inpatients in general wards and intensive care units (ICU) in Germany and is increasingly found in France, South Asia, and even China (<xref ref-type="bibr" rid="B65">Yang et al., 2012</xref>; <xref ref-type="bibr" rid="B50">Schleicher et al., 2013</xref>; <xref ref-type="bibr" rid="B21">Ji et al., 2014</xref>; <xref ref-type="bibr" rid="B22">Jones et al., 2015</xref>; <xref ref-type="bibr" rid="B3">Al Atrouni et al., 2016</xref>; <xref ref-type="bibr" rid="B53">Singkham-In and Chatsuwan, 2018</xref>).</p>
<p>The emergence of carbapenem-resistant bacteria has been a significant challenge to clinicians worldwide with limited therapeutic options. Tigecycline is a member of the glycylcyclines and serves as a last resort to treat multidrug-resistant (including carbapenem-resistant) <italic>Acinetobacter</italic> infections (<xref ref-type="bibr" rid="B66">Yang et al., 2017</xref>). The resistance mechanism of <italic>Acinetobacter</italic> spp. to carbapenem antibiotics is based on the production of the carbapenem-hydrolyzing class D &#x03B2;-lactamases (CHDLs), such as <italic>bla</italic><sub>OXA&#x2013;23&#x2013;like</sub> (<xref ref-type="bibr" rid="B53">Singkham-In and Chatsuwan, 2018</xref>), <italic>bla</italic><sub>OXA&#x2013;24&#x2013;like</sub> (<xref ref-type="bibr" rid="B21">Ji et al., 2014</xref>), <italic>bla</italic><sub>OXA&#x2013;58&#x2013;like</sub> (<xref ref-type="bibr" rid="B21">Ji et al., 2014</xref>), <italic>bla</italic><sub>OXA&#x2013;72&#x2013;like</sub> (<xref ref-type="bibr" rid="B36">Montealegre et al., 2012</xref>), and other variants. They can be intrinsic and have a limited ability to hydrolyze carbapenems, but can also result in a resistant phenotype, particularly when overproduced (<xref ref-type="bibr" rid="B57">Tietgen et al., 2021</xref>). There are three characterized resistance-nodulation-cell division (RND) efflux pumps: AdeABC, AdeFGH, and AdeIJK. They have been linked to antibiotic resistance, especially tigecycline resistance. Among them, the AdeABC and AdeIJK efflux pumps have been shown to play a major role in tigecycline resistance (<xref ref-type="bibr" rid="B47">Ruzin et al., 2007</xref>; <xref ref-type="bibr" rid="B31">Leus et al., 2018</xref>). In contrast to intrinsic determinants, acquired antibiotic resistance, such as New Delhi metallo-&#x03B2;-lactamase (NDM), has recently gained importance and contributed to reduced susceptibility of the <italic>Acinetobacter</italic> species. Specifically, the emergence of NDM-1-producing <italic>A. pittii</italic> was first reported in China, (<xref ref-type="bibr" rid="B65">Yang et al., 2012</xref>), followed by other regions, such as Korea (<xref ref-type="bibr" rid="B55">Sung et al., 2015</xref>), France (<xref ref-type="bibr" rid="B38">Pailhori&#x00E8;s et al., 2017</xref>), and Denmark (<xref ref-type="bibr" rid="B19">Hammerum et al., 2015</xref>) before spreading around the world.</p>
<p>The objectives of the present study were to systematically analyze the tigecycline-resistant <italic>A. pittii</italic> isolated from an ICU patient, which co-produces <italic>bla</italic><sub><italic>NDM&#x2013;1</italic></sub> and <italic>bla</italic><sub>OXA&#x2013;1045</sub>. As a result, a novel OXA enzyme was found and its active spectrum was identified. The strain was also described using an antimicrobial susceptibility profile, biofilm-forming ability, <italic>Galleria mellonella</italic> infection model, expression of efflux pump-related genes, conjunction experiment, and whole-sequence analysis.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Data Collection, Bacterial Isolate, and Susceptibility Testing</title>
<p>A total of 104 non-duplicate <italic>Acinetobacter</italic> spp. isolates were obtained between January 2020 and April 2021 in the Affiliated Hospital of Southwest Medical University. Bacterial identification was confirmed by matrix-assist laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker, Bremen, Germany) and 16s rRNA sequencing (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasheet 1</xref>). The antimicrobial susceptibility profiles were tested by MicroScan Walk-Away 96 Plus system (Siemens, Germany). The minimum inhibitory concentrations (MICs) of meropenem, imipenem, tigecycline, and colistin were determined using the broth microdilution method, and results were interpreted following the Clinical and Laboratory Standards Institute 2020 standards (<xref ref-type="bibr" rid="B9">CLSI, 2020</xref>). <italic>Escherichia coli</italic> ATCC25922 and <italic>Pseudomonas aeruginosa</italic> ATCC27853 were used as a quality control. ATCC19606 (lab-WT) was used as the reference strain in this study.</p>
</sec>
<sec id="S2.SS2">
<title>Whole-Genome Sequencing and Sequence Analysis</title>
<p>Genomic DNA of <italic>Acinetobacter pittii</italic> AP2044 strain was extracted using a DNA extraction kit (Qiagen, Hilden, Germany) and then sequenced using the Illumina NovaSeq 6000 PE150 (Illumina Inc, San Diego, CA, United States) and nanopore platforms (Sangon Biotech, Shanghai, China). Read sequences were <italic>de novo</italic> assembled using Canu workflow (v1.7) (<xref ref-type="bibr" rid="B27">Koren et al., 2017</xref>). Prokka (v1.10) was utilized to predict coding genes, tRNA, and rRNA in the assembled genome <xref ref-type="bibr" rid="B49">Seemann, 2014</xref>. All genomic data were uploaded in the National Center for Biotechnology Information (NCBI) database under the accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP087716">CP087716</ext-link>-<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP087718">CP087718</ext-link>. A novel OXA variant was then identified and termed OXA-1045 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="OL790815">OL790815</ext-link>). The ResFinder<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> and NCBI BLAST<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> were used to determine the acquired resistance genes. The GC Content Calculator web tool<sup><xref ref-type="fn" rid="footnote3">3</xref></sup> was used to measure the GC ratio. Additionally, the IS finder<sup><xref ref-type="fn" rid="footnote4">4</xref></sup> and VFDB<sup><xref ref-type="fn" rid="footnote5">5</xref></sup> databases were used to determine the insertion sequence (IS) elements and virulence genes. The genomic island (GI) sequences were predicted based on GI prediction software packages (IslandPATH-DIMOB) (<xref ref-type="bibr" rid="B20">Hsiao et al., 2003</xref>). Chromosome comparison was performed using BLAST Ring Image Generator (BRIG) in the default settings (<xref ref-type="bibr" rid="B5">Alikhan et al., 2011</xref>).</p>
</sec>
<sec id="S2.SS3">
<title>Conjugation</title>
<p>As previously mentioned, mating experiments were conducted in broth and on filters using <italic>Escherichia coli</italic> J53 AizR (an azide resistant strain of J53) as the recipient at 37&#x00B0;C (<xref ref-type="bibr" rid="B17">Fu et al., 2012</xref>). Potential transconjugants were selected on Luria-Bertani (LB) broth agar plates containing 0.5 mg/L of imipenem and 180 mg/L of sodium azide (<xref ref-type="bibr" rid="B64">Xiang et al., 2020</xref>). Transconjugants were verified by MALDI-TOF MS and polymerase chain reaction (PCR), respectively.</p>
</sec>
<sec id="S2.SS4">
<title>Characterization of the New &#x03B2;-Lactamase OXA-1045</title>
<p>Sequence alignment of OXA-1045 with OXA-213 was investigated using Clustal Omega (<xref ref-type="bibr" rid="B52">Sievers et al., 2011</xref>) and ESPript 3.0<sup><xref ref-type="fn" rid="footnote6">6</xref></sup>. The secondary structure of OXA-1045 &#x03B2;-lactamase was predicted using the JPred4 online tool<sup><xref ref-type="fn" rid="footnote7">7</xref></sup>, which is based on neural networks. To investigate the phylogenetic relationship of OXA-213-like proteins, we collected a total of 78 OXA amino acid sequences from Beta-Lactamase DataBase (BLDB)<sup><xref ref-type="fn" rid="footnote8">8</xref></sup> (accessed 11 March 2022). Protein sequence alignment of these aa sequences and of OXA-1045 was computed using Clustal Omega. This alignment was used to reconstruct the maximum-likelihood phylogeny by MEGA 7.0 (<xref ref-type="bibr" rid="B28">Kumar et al., 2016</xref>).</p>
</sec>
<sec id="S2.SS5">
<title>Cloning of &#x03B2;-Lactamase Genes and Expression</title>
<p>To evaluate the impact of resistance-determinant genes on MICs, <italic>bla</italic><sub>OXA&#x2013;1045</sub> and <italic>bla</italic><sub>OXA&#x2013;213</sub> were cloned into the vector pET28b (MiaoLingBio, Wuhan, China). To make pET28b-OXA1045 and pET28b-OXA213, PCR amplification and vector pET-28b were digested with <italic>Bam</italic>HI and <italic>Xho</italic>I and then ligated to the pET-28b vector (Invitrogen, Carlsbad, California, United States). As previously described, the generated plasmid was chemically converted into <italic>E. coli</italic> strain BL21 (Sigma-Aldrich, St. Louis, MO, United States) (<xref ref-type="bibr" rid="B34">Liu et al., 2021</xref>). Potential transformants containing pET28b-OXA1045 were identified on LB agar plates (Sigma-Aldrich, St. Louis, MO, United States) containing 20 mg/L of kanamycin (TransGen, Beijing, China). PCR primers PET28AVF2/PET-VF were used to screen colonies on plates, followed by Sanger sequencing (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasheet 1</xref>). The empty vector pET-28b was turned into BL21 for use as a control.</p>
<p>MICs of ampicillin, ampicillin-sulbactam, piperacillin, piperacillin-tazobactam, oxacillin, cefazolin, cefoxitin, cefuroxime, ceftazidime, cefotaxime, imipenem, and meropenem for the transformants containing pET28b-OXA1045 (BL21:pET28b-OXA1045) and pET28b-OXA213 (BL21:pET28b-OXA213) were determined by the broth microdilution method. MICs for ampicillin in the presence of 4 mg/L of sulbactam were also determined based on the methods used to establish MICs for piperacillin-tazobactam.</p>
</sec>
<sec id="S2.SS6">
<title>Biofilm Formation Assay</title>
<p>The biofilm formation ability of AP2044 strain and lab-WT was determined by the crystal violet staining method and field-emission scanning electron microscope (FE-SEM) as described previously with minor adjustment. Briefly, the strains were cultured overnight and adjusted to a final OD<sub>600</sub> of 0.1. A total of 20 &#x03BC;L of each bacterial suspension and 180 &#x03BC;L of LB broth (Haibo, Qingdao, China) were inoculated into a 96-well polystyrene microtiter plate (Costar#3524, Corning, United States) in triplicate. After incubation at 37&#x00B0;C overnight, the plate was washed with phosphate-buffered saline (PBS, Solarbio, Beijing, China) to remove planktonic cells, and the plate was stained with crystal violet (Solarbio, Beijing, China) and solubilized with 95% ethanol (v/v), after which its absorbance was measured at 570 nm.</p>
<p>In addition, the biofilm formation capacity of each strain was used for SEM analysis. Biofilms were cultured for 24 h on coverslips as described above and planktonic cells were removed using PBS. First, the cells were fixed with 2.5% glutaraldehyde in PBS for 4 h. Second, the cells were gently washed with PBS twice. The samples were then gradually treated with ethanol (30, 50, 70, 80, 90, and 100%) for 20 min at each concentration. The dried samples were coated with platinum and visualized using FE-SEM (Thermo Fisher Scientific, Waltham, Massachusetts, United States).</p>
</sec>
<sec id="S2.SS7">
<title><italic>Galleria mellonella</italic> Infection Model</title>
<p>Prior to all injections, <italic>Galleria mellonella</italic> larvae were stored at 20&#x00B0;C for 4 h to increase susceptibility to infection. A total of 10 &#x03BC;L of bacterial suspension of AP2044 strain and lab-WT were injected into the last left proleg of <italic>G. mellonella</italic> larvae and incubated at 37&#x00B0;C. Larvae were scored for survival every 24 h for 7 days of incubation. Then, 15 larvae were injected at a concentration of 10<sup>6</sup>CFU/mL of each strain, which was repeated three times. A negative control group (10 &#x03BC;L of PBS buffer were injected) was set for each batch of experiments. Larvae were identified as dead when failure to move in response to external touch was noted (<xref ref-type="bibr" rid="B25">Kim et al., 2021</xref>).</p>
</sec>
<sec id="S2.SS8">
<title>RNA Isolation and qPCR</title>
<p>Total RNA extraction and reverse transcription were conducted according to a previously described protocol (<xref ref-type="bibr" rid="B56">Tang et al., 2020</xref>). The quantitative reverse transcription-PCR (qRT-PCR) was used to detect the expression level of efflux pump-related genes (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasheet 1</xref>). The 2 <sup>&#x2013;&#x0394;&#x0394;Ct</sup> method was used to calculate the fold change of mRNA expression. The relative gene expression level was compared to the control sample (tigecycline-susceptible <italic>A. pittii</italic>, TSAP) (<xref ref-type="bibr" rid="B48">Salehi et al., 2021</xref>), which was assigned a value of 1 arbitrary unit. All assays were performed in triplicate in three independent cultures.</p>
</sec>
</sec>
<sec id="S3" sec-type="results|discussion">
<title>Results and Discussion</title>
<sec id="S3.SS1">
<title>Bacterial Isolate</title>
<p>A total of 69 carbapenem-resistant <italic>Acinetobacter</italic> spp. samples were obtained from sputum (40, 58%), urine (13, 18.8%), secreta (6, 8.7%), pleural fluid (6, 8.7%), and blood (4, 5.8%). The majority of them (35, 50.7%) was collected from the ICU. Among these clinical isolates, 36 (52.2%) were considered as extensively drug-resistant (XDR, the isolates are resistant to all antimicrobial classes, except colistin and/or tigecycline). Surprisingly, only the AP2044 strain was resistant to tigecycline. The MICs of the AP2044 strain increased drastically compared to the MICs of ATCC19606 among all tested antibiotics (<xref ref-type="table" rid="T1">Table 1</xref>). The increases were eightfold for gentamicin, 16-fold for piperacillin, more than 32-fold for ciprofloxacin, 64-fold for tigecycline more than 256-fold for carbapenems, more than 64-fold for tetracycline, and in the range more than 32&#x2013;256-fold for cephalosporins. However, MICs of colistin were almost the same between the two strains, which meant that they are all susceptible to colistin. The AP2044 strain was recovered from a patient with a lung tumor who underwent multiple surgical and invasive procedures at the ICU. With previous treatments of ceftazidime, sulperazon, and moxifloxacin, the patient was polymicrobial-positive, which included <italic>Pseudomonas aeruginosa, A. pittii</italic>, and <italic>Stenotrophomonas maltophilia.</italic></p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>MICs (mg/L) of common antibiotics in AP2044 and ATCC19606.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">AP2044</td>
<td valign="top" align="center">ATCC19606</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Gentamicin</td>
<td valign="top" align="center">256</td>
<td valign="top" align="center">32</td>
</tr>
<tr>
<td valign="top" align="left">Meropenem</td>
<td valign="top" align="center">256</td>
<td valign="top" align="center">&#x003C;1</td>
</tr>
<tr>
<td valign="top" align="left">Imipenem</td>
<td valign="top" align="center">256</td>
<td valign="top" align="center">&#x003C;1</td>
</tr>
<tr>
<td valign="top" align="left">Ciprofloxacin</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">&#x003C;1</td>
</tr>
<tr>
<td valign="top" align="left">Ceftazidime</td>
<td valign="top" align="center">&#x003E;1,024</td>
<td valign="top" align="center">4</td>
</tr>
<tr>
<td valign="top" align="left">Ceftriaxone</td>
<td valign="top" align="center">&#x003E;1,024</td>
<td valign="top" align="center">32</td>
</tr>
<tr>
<td valign="top" align="left">Cefotaxime</td>
<td valign="top" align="center">&#x003E;1,024</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">Cefepime</td>
<td valign="top" align="center">&#x003E;1,024</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">Tetracycline</td>
<td valign="top" align="center">&#x003E;128</td>
<td valign="top" align="center">2</td>
</tr>
<tr>
<td valign="top" align="left">Tigecycline</td>
<td valign="top" align="center">64</td>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Piperacillin</td>
<td valign="top" align="center">512</td>
<td valign="top" align="center">32</td>
</tr>
<tr>
<td valign="top" align="left">Colistin</td>
<td valign="top" align="center">&#x003C;0.5</td>
<td valign="top" align="center">&#x003C;0.5</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S3.SS2">
<title>Conjugation and Whole-Genome Analysis of AP2044</title>
<p>The genome of AP2044 was assembled into three contigs of 4,248,736 bp, consisting of one chromosomal backbone and two plasmids. The chromosome, pAP2044-1, and pAP2044-2 had 3,921,810, 283,349, and 43,577 bp and 39, 39.4, and 39.14% G + C content, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). The genome had 18 rRNA operons, 74 tRNAs, and 4,128 predicted protein coding sequences. Indeed, conjugation experiments of the AP2044 strain failed to transfer the plasmid into an <italic>E. coli</italic> recipient. Antimicrobial resistance can be acquired through horizontal gene transfer (HGT) of antibiotic resistance genes (ARGs) and plasmids are critical for HGT and serve as a support for other mobile genetic elements (MGEs) (<xref ref-type="bibr" rid="B61">Vrancianu et al., 2020</xref>). The plasmid carrying <italic>bla</italic><sub>NDM&#x2013;1</sub>, pAP2044-1, is similar to plasmid pXBB1-9 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP010351.1">CP010351.1</ext-link>) from <italic>Acinetobacter johnsonii</italic> and pALWED1.1 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="KX426227.1">KX426227.1</ext-link>) from <italic>Acinetobacter lwoffii</italic>. pAP2044-2 plasmid shows similarity among the sequenced plasmids to p1_010059 from <italic>Acinetobacter junii</italic> (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP028798.2">CP028798.2</ext-link>) and pACI-235c from <italic>Acinetobacter</italic> sp. (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP026414.1">CP026414.1</ext-link>). We speculated that pAP2044-1 and pAP2044-2 plasmids have narrow bacterial host spectrums, which may have a dominant transmission in <italic>Acinetobacter</italic> spp. The genome analyses demonstrated that the AP2044 strain possessed a total of 12 ARGs linked to five different classes of antibiotics, including carbapenem, &#x03B2;-lactam, aminoglycoside, macrolide, and sulfonamide (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). The GC content of a gene can be compared to the whole genome of an organism to determine if that gene comes from that organism. If this is the case, the two GC content profiles are likely to be the same (<xref ref-type="bibr" rid="B15">Evans and Amyes, 2014</xref>). Furthermore, the GC ratios (50&#x2013;60%) of several ARGs, including <italic>bla</italic><sub>NDM&#x2013;1</sub>, <italic>aac(3&#x2033;)-IIb, aph(3&#x2033;)-Ib, aph(6)-Id</italic>, and <italic>sul2</italic>, were much greater than those of the chromosomal backbone (39.46%), implying that the ARGs were acquired from other bacterial species. Therefore, we used the Center for Genomic Epidemiology database<sup><xref ref-type="fn" rid="footnote9">9</xref></sup> to examine the homology of the ARGs to see if they originated from other bacterial species. Eight of the 12 ARGs appeared to be originating from other pathogens, with gene homologies exceeding 99% identities (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Genome characteristics of <italic>Acinetobacter pittii</italic> strain AP2044.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Context</td>
<td valign="top" align="center">Size (bp)</td>
<td valign="top" align="center">G + C (%)</td>
<td valign="top" align="center">No. of predicted ORFs</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Chromosome</td>
<td valign="top" align="center">3,921,810</td>
<td valign="top" align="center">39.0</td>
<td valign="top" align="center">3,795</td>
</tr>
<tr>
<td valign="top" align="left">Plasmid pAP2044-1</td>
<td valign="top" align="center">283,349</td>
<td valign="top" align="center">39.4</td>
<td valign="top" align="center">290</td>
</tr>
<tr>
<td valign="top" align="left">Plasmid pAP2044-2</td>
<td valign="top" align="center">43,577</td>
<td valign="top" align="center">39.1</td>
<td valign="top" align="center">47</td>
</tr>
</tbody>
</table></table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p><bold>(A)</bold> Chromosomal genomic sequence of <italic>A. pittii</italic> AP2044 strain. Alignment of AP2044 with DUT2, HUMV-6483, and WCHAP005069. AP2044 is the closest to DUT2 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP014651.1">CP014651.1</ext-link>) and HUMV-6483 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP021428.1">CP021428.1</ext-link>). HUMV-6483 was recovered in a hospital of a neighboring city (Chengdu, China) in 2018, with an 89% coverage and 96.47% identity. Annotations are provided by ResFinder<sup>1</sup>, IS Finder<sup>4</sup>, and VFDB<sup>5</sup> analysis. <bold>(B)</bold> Genetic environment of <italic>bla</italic><sub>NDM&#x2013;1</sub> located on chromosome and pAP2044-1 from AP2044 strain. <bold>(C)</bold> Genetic environment of <italic>bla</italic><sub>OXA&#x2013;1045</sub> from AP2044 strain.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-868152-g001.tif"/>
</fig>
<table-wrap position="float" id="T3">
<label>TABLE 3</label>
<caption><p>Resistance gene distribution in <italic>Acinetobacter pittii</italic> strain AP2044.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">Resistance gene</td>
<td valign="top" align="center">Identity%</td>
<td valign="top" align="center">Query/template length</td>
<td valign="top" align="center">Position in context</td>
<td valign="top" align="center">Predicted phenotype</td>
<td valign="top" align="center">Source</td>
<td valign="top" align="center">GC content of AR gene (%)</td>
<td valign="top" align="center">Accession number</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Chromosome</td>
<td valign="top" align="center"><italic>bla</italic><sub>NDM&#x2013;1</sub></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">813/813</td>
<td valign="top" align="center">3178789.3179601</td>
<td valign="top" align="center">Beta-lactam resistance</td>
<td valign="top" align="center"><italic>Klebsiella pneumoniae</italic> plasmid pKpANDM-1</td>
<td valign="top" align="center">61</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="FN396876">FN396876</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>bla</italic><sub>ADC&#x2013;25</sub></td>
<td valign="top" align="center">91.93</td>
<td valign="top" align="center">1,152/1,152</td>
<td valign="top" align="center">1279039.1280190</td>
<td valign="top" align="center">Beta-lactam resistance</td>
<td valign="top" align="center"><italic>Acinetobacter baumannii</italic> strain</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="EF016355">EF016355</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>bla</italic><sub>OXA&#x2013;1045</sub></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">822/822</td>
<td valign="top" align="center">2227748.2228569</td>
<td valign="top" align="center">Beta-lactam resistance</td>
<td valign="top" align="center"><italic>Acinetobacter pittii strain</italic> AP2044</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="OL790815">OL790815</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">pAP2044-1</td>
<td valign="top" align="center"><italic>aac(3&#x2033;)-IIb</italic></td>
<td valign="top" align="center">99.88</td>
<td valign="top" align="center">861/861</td>
<td valign="top" align="center">24804.25664</td>
<td valign="top" align="center">Aminoglycoside resistance</td>
<td valign="top" align="center"><italic>Escherichia coli</italic></td>
<td valign="top" align="center">58</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="EU022314">EU022314</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>aph(3&#x2032;)-Via</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">780/780</td>
<td valign="top" align="center">201505.202284</td>
<td valign="top" align="center">Aminoglycoside resistance</td>
<td valign="top" align="center"><italic>Acinetobacter baumannii</italic></td>
<td valign="top" align="center">32</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="X07753">X07753</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>bla</italic><sub>NDM&#x2013;1</sub></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">813/813</td>
<td valign="top" align="center">194810.195622</td>
<td valign="top" align="center">Beta-lactam resistance</td>
<td valign="top" align="center"><italic>Klebsiella pneumoniae</italic> plasmid pKpANDM-1</td>
<td valign="top" align="center">61</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="FN396876">FN396876</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">pAP2044-2</td>
<td valign="top" align="center"><italic>aph(3&#x2033;)-Ib</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">804/804</td>
<td valign="top" align="center">22734.23537</td>
<td valign="top" align="center">Aminoglycoside resistance</td>
<td valign="top" align="center"><italic>Shigella flexneri</italic> plasmid Pstr1</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="AF321551">AF321551</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>aph(6)-Id</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">837/837</td>
<td valign="top" align="center">23537.24373</td>
<td valign="top" align="center">Aminoglycoside resistance</td>
<td valign="top" align="center"><italic>Escherichia coli</italic> plasmid RSF1010</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="M28829">M28829</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>mph(E)</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">885/885</td>
<td valign="top" align="center">6420.7304</td>
<td valign="top" align="center">Macrolide resistance</td>
<td valign="top" align="center">Uncultured bacterium plasmid pRSB105</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="DQ839391">DQ839391</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>msr(E)</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">1,476/1,476</td>
<td valign="top" align="center">4889.6364</td>
<td valign="top" align="center">Macrolide, Lincosamide and Streptogramin B resistance</td>
<td valign="top" align="center"><italic>Pasteurella multocida</italic></td>
<td valign="top" align="center">39</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="FR751518">FR751518</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>sul2</italic></td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">816/816</td>
<td valign="top" align="center">20562.21377</td>
<td valign="top" align="center">Sulfonamide resistance</td>
<td valign="top" align="center"><italic>Vibrio cholerae</italic></td>
<td valign="top" align="center">60</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="AY034138">AY034138</ext-link></td>
</tr>
<tr>
<td/>
<td valign="top" align="center"><italic>tet(39)</italic></td>
<td valign="top" align="center">99.91</td>
<td valign="top" align="center">1,122/1,122</td>
<td valign="top" align="center">8331.9452</td>
<td valign="top" align="center">Tetracycline resistance</td>
<td valign="top" align="center"><italic>Acinetobacter baumannii</italic> strain RCH52 plasmid pRCH52-1</td>
<td valign="top" align="center">40</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="KT346360">KT346360</ext-link></td>
</tr>
</tbody>
</table></table-wrap>
<p>Bacterial survival tactics against aminoglycoside antibiotics include altering enzymes to inactivate aminoglycosides, increasing efflux pump production, lowering membrane permeability, and interfering with aminoglycoside binding <italic>via</italic> modification of 16S ribosomal RNA (<xref ref-type="bibr" rid="B54">Su et al., 2018</xref>). Interestingly, the AP2044 genome has four distinct aminoglycoside resistance genes, conferring remarkable cell resistance to a wide variety of aminoglycoside antibiotics (eightfold greater than ATCC19606, <xref ref-type="table" rid="T1">Table 1</xref>, and <xref ref-type="supplementary-material" rid="DS1">Supplementary Datasheet 2</xref>). Two genes [<italic>aac(3&#x2033;)-IIb</italic> and <italic>aph(6)-Id</italic>] were most likely transmitted from <italic>E. coli</italic>, whereas one <italic>aph(3&#x2033;)-Ib</italic> gene was likely transferred from <italic>Shigella flexneri</italic>. This might add phosphate, acetyl, adenyl, or methyl groups to aminoglycosides to alter them. Macrolide antibiotics inhibit protein synthesis by targeting the bacterial ribosome (<xref ref-type="bibr" rid="B60">V&#x00E1;zquez-Laslop and Mankin, 2018</xref>). Furthermore, the <italic>msr(E)</italic> gene in the AP2044 strain&#x2019;s genome, which comes from <italic>Pasteurella multocida via</italic> HGT, may protect ribosomes from macrolides. Under antibiotic selection pressure, random mutations, ARG acquisition <italic>via</italic> HGT, and activation of mobile DNA elements are viable mechanisms (<xref ref-type="bibr" rid="B48">Salehi et al., 2021</xref>). Surprisingly, the XDR <italic>A. pittii</italic> AP2044 strain most likely acquired many ARGs <italic>via</italic> HGT, resulting in high levels of resistance to the majority of the antibiotics tested (<xref ref-type="table" rid="T1">Table 1</xref>). Additionally, a total of four different IS elements next to the ARGs are found in AP2044 plasmids. Several different IS elements were identical (100%) to IS<italic>Alw125</italic>, IS<italic>17</italic>, and IS<italic>Aba2</italic> of <italic>Acinetobacter</italic> spp., which are adjacent to the <italic>aph(3&#x2032;)-VIa,aph(3&#x2033;)-Ib</italic>, and <italic>sul2</italic> genes. The <italic>aac(3&#x2033;)-IIb</italic> gene was located between two IS<italic>30</italic> family elements. As a result, the AP2044 strain&#x2019;s remarkable XDR capacity was related to the enormous amount of ARGs and IS elements in its genome.</p>
<p>Interestingly, the AP2044 strain had a high level of carbapenem resistance and carried the <italic>bla</italic><sub>NDM&#x2013;1</sub> gene. The presence of NDM, a widespread metallo-&#x03B2;-lactamase (MBL) in <italic>Acinetobacter</italic> was noteworthy (<xref ref-type="bibr" rid="B39">Perez et al., 2007</xref>). The increased number and diversity of MBLs in <italic>Acinetobacter</italic> spp. indicated a concerning trend in the global emergence of resistance in this pathogen (<xref ref-type="bibr" rid="B14">Dortet et al., 2014</xref>). In <italic>Acinetobacter</italic>, the <italic>bla</italic><sub>NDM</sub>-type genes were located on either the plasmid or chromosome (<xref ref-type="bibr" rid="B63">Wong et al., 2017</xref>). Nevertheless, the AP2044 strain carried two copies of <italic>bla</italic><sub><italic>NDM&#x2013;1</italic></sub> genes, which are located on both the plasmid and chromosome. The <italic>bla</italic><sub>NDM&#x2013;1</sub> gene is typically located between two copies of the IS<italic>Aba125</italic> element in NDM-producing <italic>A. baumannii</italic>, forming a composite transposon termed Tn<italic>125</italic> (<xref ref-type="bibr" rid="B7">Bonnin et al., 2012</xref>, <xref ref-type="bibr" rid="B8">2014</xref>; <xref ref-type="bibr" rid="B26">Krahn et al., 2016</xref>). Except for the insertion of an IS<italic>91</italic> family transposon and deletion of <italic>insE</italic>, the genetic context of <italic>bla</italic><sub>NDM&#x2013;1</sub> on the chromosome was similar to that of Tn<italic>125</italic>. Indeed, by the late 1970s, a worldwide lineage of <italic>A. baumannii</italic> had gained resistance to conventionally known antibiotic families. Further resistance was acquired in transposon lineages in the 1980s as new antibiotics became available (<xref ref-type="bibr" rid="B6">Blackwell et al., 2016</xref>). Transposon Tn<italic>125</italic> proved to be the primary vehicle for the spread of <italic>bla</italic><sub>NDM&#x2013;1</sub> in <italic>Acinetobacter</italic> spp. (<xref ref-type="bibr" rid="B41">Poirel et al., 2012</xref>). Current observations suggested that the <italic>bla</italic><sub>NDM&#x2013;1</sub> gene originated from an unknown environmental bacterial progenitor species and was integrated into the chromosome of <italic>Acinetobacter</italic> spp. The <italic>bla</italic><sub>NDM&#x2013;1</sub>-bearing Tn<italic>125</italic> transposon was most likely derived from such <italic>Acinetobacter</italic> spp. and then transferred to broad-host-range plasmids before being horizontally transferred to <italic>Enterobacteriaceae</italic> and <italic>P. aeruginos</italic>a (<xref ref-type="bibr" rid="B37">Nordmann et al., 2012</xref>; <xref ref-type="bibr" rid="B8">Bonnin et al., 2014</xref>). Of greater interest was that this NDM-1 producer carried the structure (IS<italic>30</italic>-<italic>bla</italic><sub>NDM&#x2013;1</sub>-<italic>ble</italic><sub><italic>MBL</italic></sub>-<italic>trpF</italic>-ORF-Y-family DNA polymerase-<italic>umuD</italic>-ORF-ORF-ORF-IS<italic>Aha3</italic>) surrounding the <italic>bla</italic><sub>NDM&#x2013;1</sub> gene (<xref ref-type="fig" rid="F1">Figure 1B</xref>), which was similar to that found in pAcsw19-2 (Sichuan, Luzhou) (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP043309.1">CP043309.1</ext-link>). These two plasmids originate in the same area, and the personnel mobility is substantial. Moreover, sewage is the origin of pAcsw19-2. Several investigations have suggested that it could be a major source of resistance genes as well as a hotspot for transmitting resistance genes and MGEs to clinical microorganisms. Moreover, the possibility of gene cluster transfer should be considered due to the diversity of the <italic>bla</italic><sub>NDM&#x2013;1</sub> gene environment. In addition, a massive resistance island in the <italic>Acinetobacter</italic>&#x2019;s genome (<xref ref-type="bibr" rid="B1">Adams et al., 2008</xref>) could acquire additional genetic entities for resistance from other bacterial species. Genomic island GI_AP2044-4 (42,734 bp) carried the chromosome-borne <italic>bla</italic><sub>NDM&#x2013;1</sub>. Sequence analysis showed that GI_AP2044-4 had 90% query cover and 98.8% sequence similarities with the DNA sequence of <italic>A. pittii</italic> strain ST220 chromosome (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP029610.1">CP029610.1</ext-link>) genome (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasheet 3</xref>).</p>
</sec>
<sec id="S3.SS3">
<title>Identification of the Novel &#x03B2;-Lactamase OXA-1045 and Genetic Environment of <italic>bla</italic><sub>OXA&#x2013;1045</sub></title>
<p>Previously, two &#x03B2;-lactamase genes located on the chromosome were identified by WGS. One gene encoding an ADC-25-like cephalosporinase and another gene encoding a novel OXA variant were determined to have an 89% aa identity (243/273 aa) and 100% coverage (273/273 aa) compared to OXA-213. The aa sequences of OXA enzymes are quite diverse, and a cutoff of 73.1% of aa identity has recently been proposed as a criterion for dividing OXA subfamilies (<xref ref-type="bibr" rid="B68">Yoon and Jeong, 2021</xref>). Therefore, the novel OXA variant belonged to the OXA-213-like subfamily. The Pathogen Detection group at GenBank&#x2019;s National Center for Biotechnology Information has awarded it the number OXA-1045 (accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="OL790815">OL790815</ext-link>) (<xref ref-type="bibr" rid="B15">Evans and Amyes, 2014</xref>; <xref ref-type="bibr" rid="B68">Yoon and Jeong, 2021</xref>). Sequence alignment of OXA-1045 with OXA-213 revealed 30 aa changes and the secondary structure of OXA-1045 contained nine &#x03B1; helixes and six &#x03B2; sheets (<xref ref-type="fig" rid="F2">Figure 2</xref>). <italic>Acinetobacter</italic> isolates have shown complex interactions with multiple mechanisms of resistance to carbapenems, and the production of naturally occurring OXAs has been the most frequently observed. The predominance of OXAs (OXA-23, OXA-24 or &#x2013;40, OXA-51, OXA-58, and OXA-143) is the major reason for phenotypic resistance to carbapenems, which have been detected in many parts of the world (<xref ref-type="bibr" rid="B2">Adams-Haduch et al., 2011</xref>; <xref ref-type="bibr" rid="B43">Principe et al., 2014</xref>; <xref ref-type="bibr" rid="B23">Kamolvit et al., 2015</xref>; <xref ref-type="bibr" rid="B29">Labarca et al., 2016</xref>). Among these carbapenem-hydrolyzing OXA-type lactamases, <italic>bla</italic><sub>OXA&#x2013;23</sub> is regarded as an intrinsic gene of <italic>Acinetobacter radioresistens</italic>, OXA-51 is intrinsic to <italic>A. baumannii</italic> and the OXA-134 variant is intrinsic to <italic>Acinetobacter schindleri</italic> and <italic>A. lwoffii</italic> (<xref ref-type="bibr" rid="B42">Poirel et al., 2008</xref>; <xref ref-type="bibr" rid="B58">Turton et al., 2012</xref>; <xref ref-type="bibr" rid="B40">P&#x00E9;richon et al., 2014</xref>). OXA-213-like enzymes have been identified to be intrinsic to <italic>A. calcoaceticus</italic> and have been subsequently detected in <italic>A. pittii</italic> (<xref ref-type="bibr" rid="B16">Figueiredo et al., 2012</xref>; <xref ref-type="bibr" rid="B57">Tietgen et al., 2021</xref>). Phylogenetic analysis of OXA-213-like proteins identified two distinct subgroups within the OXA family. The first group was linked to <italic>A. pittii</italic> and the second group to <italic>A. calcoaceticus</italic> (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><bold>(A)</bold> Clustal Omega and ESPript 3.0 were used to align the amino acid sequences of OXA-822 and OXA-213. Residues that have been conserved are highlighted in boxes. <bold>(B)</bold> Secondary structure of OXA-1045. The secondary structure was predicted using the neural network-based web service JPred4 with the default settings. Secondary structure elements, &#x03B1; helixes, &#x03B2; sheets.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-868152-g002.tif"/>
</fig>
<p>The genetic environment of <italic>bla</italic><sub>OXA&#x2013;1045</sub> from the AP2044 strain is shown in <xref ref-type="fig" rid="F1">Figure 1C</xref>. The <italic>fxsA</italic> gene, which is situated upstream of the <italic>bla</italic><sub><italic>OXA&#x2013;1045</italic></sub> gene, encoded the cytoplasmatic membrane protein. A potential redox protein-coding gene <italic>osmC</italic>-like, a transketolase protein-coding gene <italic>tkt</italic>, and an S adenosylmethionine synthase-coding gene <italic>metK</italic> were positioned upstream of <italic>fxsA</italic>. All <italic>bla</italic><sub>OXA&#x2013;1045</sub> downstream genes were <italic>yncA, ruvC, nnrD</italic>, and <italic>queG</italic>, which encoded the N-acetyltransferase family protein, crossover junction endodeoxyribonuclease, bifunctional NAD(P) H-hydrate repair enzyme, and epoxyqueuosine reductase, respectively. The genetic context of <italic>bla</italic><sub>OXA&#x2013;1045</sub> showed the closest similarity with that of <italic>bla</italic><sub>OXA&#x2013;417</sub> in a BLAST search, which was naturally found on the chromosome of <italic>A. pittii</italic> and belonged to the <italic>bla</italic><sub>OXA&#x2013;213&#x2013;<italic>like</italic></sub> family. In addition, there was no mobile element found in the surrounding region of <italic>bla</italic><sub>OXA&#x2013;1045</sub>. The above findings implied that the initial location of <italic>bla</italic><sub>OXA&#x2013;1045</sub> was in the chromosome. The presence of an IS upstream of the gene, which acted as a powerful promoter, can boost the production of OXAs (<xref ref-type="bibr" rid="B59">Turton et al., 2006</xref>). Hence, there was no evidence of OXA-1045 overproduction.</p>
</sec>
<sec id="S3.SS4">
<title>Impact of OXA-1045 on Antibiotic Susceptibility to &#x03B2;-Lactams</title>
<p>Among the antibiotics tested, only the MICs of ampicillin, piperacillin, cefazolin, cefoxitin, cefuroxime, ampicillin-sulbactam, and piperacillin-tazobactam for the transformant containing pET28b-OXA1045 (BL21:pET28b-OXA1045) were increased by &#x2265; 2-fold, as compared to those for the transformant containing pET-28b (BL21:pET28b). In comparison with OXA-213, OXA-1045 elevated the MICs of piperacillin and piperacillin-tazobactam slightly, suggesting that OXA-1045 had a greater impact on piperacillin. Noteworthy, the MICs of ceftazidime, cefotaxime, meropenem, and imipenem for both transformants remained the same as the acceptor strain, demonstrating that the OXA-213 resistance profile to cephalosporins and carbapenem was similar to that of OXA-1045 (<xref ref-type="table" rid="T4">Table 4</xref>). A previous study has illustrated that the production of all OXAs led to a significant increase in all carbapenem MICs in <italic>A. baumannii</italic>, while no elevation in MICs was observed in <italic>E. coli</italic> (<xref ref-type="bibr" rid="B57">Tietgen et al., 2021</xref>). Indeed, we could not rule out the possibility that the effect on MICs is a result of endogenous OXA cooperation with vector-expressed OXA-213-like variants in <italic>Acinetobacter</italic> spp. The results indicated that carbapenemase activity of tested OXAs may be related to the species-dependent effect.</p>
<table-wrap position="float" id="T4">
<label>TABLE 4</label>
<caption><p>MICs (mg/L) of &#x03B2;-lactams.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">BL21:pET28b_ OXA1045</td>
<td valign="top" align="center">BL21:pET28b_ OXA213</td>
<td valign="top" align="center">BL21:pET28b</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Ampicillin</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
</tr>
<tr>
<td valign="top" align="left">Piperacillin</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
</tr>
<tr>
<td valign="top" align="left">Oxacillin</td>
<td valign="top" align="center">256</td>
<td valign="top" align="center">256</td>
<td valign="top" align="center">256</td>
</tr>
<tr>
<td valign="top" align="left">Cefazolin</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Cefoxitin</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.5</td>
</tr>
<tr>
<td valign="top" align="left">Cefuroxime</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">&#x003C;0.025</td>
</tr>
<tr>
<td valign="top" align="left">Ceftazidime</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
</tr>
<tr>
<td valign="top" align="left">Cefotaxime</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
</tr>
<tr>
<td valign="top" align="left">Meropenem</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
</tr>
<tr>
<td valign="top" align="left">Imipenem</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
<td valign="top" align="center">&#x003C;0.025</td>
</tr>
<tr>
<td valign="top" align="left">Ampicillin-sulbactam</td>
<td valign="top" align="center">2/4</td>
<td valign="top" align="center">2/4</td>
<td valign="top" align="center">0.5/4</td>
</tr>
<tr>
<td valign="top" align="left">Piperacillin-tazobactam</td>
<td valign="top" align="center">4/4</td>
<td valign="top" align="center">2/4</td>
<td valign="top" align="center">1/4</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S3.SS5">
<title>Biofilm Production and Detection of Virulence Phenotype</title>
<p>The biofilm formation capacity was measured in the Lab-WT and AP2044 strains. The OD<sub>570</sub> values for the Lab-WT and negative control were 0.84 &#x00B1; 0.12 and 0.14 &#x00B1; 0.008, respectively. The OD<sub>570</sub> value for the AP2044 strain was 0.177 &#x00B1; 0.045, which was a weak biofilm producer. Moreover, the SEM result was consistent with the OD<sub>570</sub> values obtained by crystal violet staining (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). The AP2044 strain presented mucoid phenotype, with moist colonies and an elevated surface (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 2</xref>). Mucoid phenotype formation may influence the virulence of pathogenic microorganisms to varying degrees, which has allowed to make significant strides in characterizing the determinants of pathogenic mechanisms in <italic>P. aeruginosa</italic> and <italic>Klebsiella pneumoniae</italic> (<xref ref-type="bibr" rid="B11">Dennis et al., 2018</xref>; <xref ref-type="bibr" rid="B12">Ding et al., 2022</xref>). A previous study has demonstrated that mucoid <italic>A. baumannii</italic> strains were more virulent than non-mucoid isolates (<xref ref-type="bibr" rid="B51">Shan et al., 2021</xref>). Therefore, we analyzed the virulence of AP2044 strain by developing a <italic>Galleria mellonella</italic> infection model. As shown in <xref ref-type="fig" rid="F3">Figure 3C</xref>, such virulence of AP2044 strain was comparable to that of the Lab-WT, which is well known for its lack of virulence (<xref ref-type="bibr" rid="B24">Khalil et al., 2021</xref>). The association between the virulence and mucoid phenotype in <italic>Acinetobacter</italic> spp. warrant further investigation. Indeed, the capacity of <italic>A. baumannii</italic> to form biofilm facilitated its survival and persistence in hospital environments (<xref ref-type="bibr" rid="B13">Donlan and Costerton, 2002</xref>; <xref ref-type="bibr" rid="B18">Gaddy et al., 2009</xref>). This, in turn, contributed to the extensive spread of this pathogen across the globe. Many virulence factors have been implicated in the initial adhesion process of biofilm (<xref ref-type="bibr" rid="B69">Zeighami et al., 2019</xref>). Likewise, biofilm development is one of the basic virulence traits of clinical isolates (<xref ref-type="bibr" rid="B24">Khalil et al., 2021</xref>). Mahmoud et al. reported biofilm formation as a potent virulence factor in <italic>A. baumanni</italic>, with the strong biofilm producers exhibiting a much greater ability to kill <italic>G. mellonella</italic> larvae than the moderate and weak biofilm producers (<xref ref-type="bibr" rid="B24">Khalil et al., 2021</xref>). Accordingly, AP2044 strain was a weak biofilm producer and a low virulence strain. Several previous studies have demonstrated that the majority of XDR and pandrug-resistant (PDR) clinical isolates were weak or non-biofilm producers, which is consistent with the present findings (<xref ref-type="bibr" rid="B44">Qi et al., 2016</xref>; <xref ref-type="bibr" rid="B33">Li et al., 2021</xref>). There may be a metabolic cost caused by high-level antibiotic resistance, which has been shown to cause a decrease in virulence (<xref ref-type="bibr" rid="B46">Roux et al., 2015</xref>). However, the emergence of carbapenem-resistant hypervirulent <italic>A. baumannii</italic> (CR-hvAB) strains presents significant challenges for public health and infection control (<xref ref-type="bibr" rid="B32">Li et al., 2020</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p><bold>(A)</bold> Crystal violet quantification of biofilm formation in the AP2044 and Lab-WT strains; Lab-WT was used as positive control and LB broth was used as negative control. <bold>(B)</bold> SEM images of the AP2044 and Lab-WT strains. <bold>(C)</bold> To compare pathogenicity <italic>in vivo</italic>, 15 <italic>Galleria mellonella</italic> larvae were infected with the common strain Lab-WT, typical hypervirulent strain NTUH-K2044, and strain AP2044 under each condition. Death was defined as a lack of reaction or melanization in infected <italic>G. mellonella</italic> at 37&#x00B0;C for 7 days. The mean (<italic>N</italic> = 15 biological replicates) is represented for the data. <bold>(D)</bold> The expression of <italic>adeB</italic>, <italic>adeG</italic>, and <italic>adeJ</italic> genes was quantified <italic>via</italic> qRT-PCR. Gene expression profiles of the strains were normalized to their respective 16S rRNA expression. Data represent the mean (&#x00B1; standard deviation, <italic>SD</italic>; <italic>N</italic> = 4&#x2013;6 biological replicates). &#x002A;<italic>P</italic> &#x003C; 0.05; &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01; &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001 by Student&#x2019;s <italic>t</italic>-test against theoretical value.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-13-868152-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS6">
<title>Relative Gene Expression</title>
<p>Compared to the reference strain, quantitative analysis demonstrated that AP2044 expressed 1. 54-, 0. 67-, and 2.05-fold more <italic>adeB, adeJ</italic>, and <italic>adeG</italic> genes, respectively (<xref ref-type="fig" rid="F3">Figure 3D</xref>). In particular, the transcription level of <italic>adeB</italic> and <italic>adeJ</italic> in AP2044 was significantly overexpressed than that in TSAP (<italic>t</italic>-test, <italic>P</italic> &#x003C; 0.01). The efflux pump plays a vital role in both biofilm formation and antibiotic resistance, particularly in tigecycline resistance (<xref ref-type="bibr" rid="B30">Lee et al., 2020</xref>). The tigecycline is one of the last resort options for XDR strain infection treatment (<xref ref-type="bibr" rid="B63">Wong et al., 2017</xref>). <italic>Acinetobacter</italic> has shown superior resistance to almost all available systemic antibiotics and demonstrates an XDR phenotype. Therefore, overcoming antibiotic resistance is the primary challenge of treating <italic>Acinetobacter</italic> infections (<xref ref-type="bibr" rid="B63">Wong et al., 2017</xref>). AdeABC in particular has been demonstrated to influence antibiotic sensitivity and to contribute to tigecycline resistance (<xref ref-type="bibr" rid="B47">Ruzin et al., 2007</xref>; <xref ref-type="bibr" rid="B45">Roca et al., 2011</xref>). The AdeRS two-component system, which consists of a sensor kinase and a response regulator, is in charge of expressing the transcription of the AdeABC efflux pumps. The aa changes or IS element insertion in the AdeRS two-component system can boost the transcription level of AdeABC efflux pumps (<xref ref-type="bibr" rid="B67">Yoon et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Luca&#x00DF;en et al., 2021</xref>). AdeIJK is regulated by the TetR-like repressor AdeN, whose overproduction results in antibiotic resistance and contributes to tigecycline resistance. The present findings indicated that AdeABC and AdeIJK overexpression was the cause of tigecycline resistance, which is consistent with previous studies. A previous study have demonstrated that the AdeABC and AdeIJK efflux systems contributed to tigecycline resistance in a synergistic manner (<xref ref-type="bibr" rid="B10">Damier-Piolle et al., 2008</xref>).</p>
</sec>
</sec>
<sec id="S4" sec-type="conclusion">
<title>Conclusion</title>
<p>In summary, the present study found that XDR <italic>A. pittii</italic> carrying two copies of <italic>bla</italic><sub>NDM&#x2013;1</sub>. The <italic>bla</italic><sub>NDM&#x2013;1</sub> was located on the chromosome and plasmid in the <italic>A. pittii</italic> strain, which highlighted the fact that <italic>bla</italic><sub>NDM&#x2013;1&#x2013;</sub>bearing the Tn<italic>125</italic> transposon was most likely a vector of communication between such <italic>Acinetobacter</italic> spp. and uncommon <italic>Enterobacteriaceae</italic> strains. Then, transfer of the antibiotic-resistant plasmid in <italic>Acinetobacter</italic> spp. deserves special attention. The present work also identified a novel OXA variant in the OXA-213 family, OXA-1045, which was able to confer a reduced susceptibility to piperacillin and piperacillin-tazobactam compared to OXA-213. Phenotypic investigations have found that the AP2044 strain was comparable to the wild-type in terms of pathogenicity but with a weaker biofilm structure. In addition, the tigecycline resistance of the AP2044 strain may be due to the overproduction of AdeABC and AdeIJK.</p>
</sec>
<sec id="S5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: NCBI GenBank; <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP087716">CP087716</ext-link>-<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP087718">CP087718</ext-link>; <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="OL790815">OL790815</ext-link>.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>JL designed this study. ZD, ZL, and YZ performed the experiments and analyzed the data. ZD and YZ wrote the manuscript. JH and TL uploaded the data and performed analysis of qRT-PCR. YL and ZZ revised the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="pudiscl1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="S7" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the grants from the Sichuan Science and Technology Program (2021YFH001 and 20QYCX0056).</p>
</sec>
<sec id="S8" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.868152/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2022.868152/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="DS1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>M. D.</given-names></name> <name><surname>Goglin</surname> <given-names>K.</given-names></name> <name><surname>Molyneaux</surname> <given-names>N.</given-names></name> <name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Lavender</surname> <given-names>H.</given-names></name> <name><surname>Jamison</surname> <given-names>J. J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Comparative genome sequence analysis of multidrug-resistant <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>190</volume> <fpage>8053</fpage>&#x2013;<lpage>8064</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00834-08</pub-id> <pub-id pub-id-type="pmid">18931120</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams-Haduch</surname> <given-names>J. M.</given-names></name> <name><surname>Onuoha</surname> <given-names>E. O.</given-names></name> <name><surname>Bogdanovich</surname> <given-names>T.</given-names></name> <name><surname>Tian</surname> <given-names>G. B.</given-names></name> <name><surname>Marschall</surname> <given-names>J.</given-names></name> <name><surname>Urban</surname> <given-names>C. M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Molecular epidemiology of carbapenem-nonsusceptible <italic>Acinetobacter baumannii</italic> in the United States.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>49</volume> <fpage>3849</fpage>&#x2013;<lpage>3854</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.00619-11</pub-id> <pub-id pub-id-type="pmid">21918019</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al Atrouni</surname> <given-names>A.</given-names></name> <name><surname>Joly-Guillou</surname> <given-names>M. L.</given-names></name> <name><surname>Hamze</surname> <given-names>M.</given-names></name> <name><surname>Kempf</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Reservoirs of non-baumannii <italic>Acinetobacter</italic> species.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<issue>49</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00049</pub-id> <pub-id pub-id-type="pmid">26870013</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almasaudi</surname> <given-names>S. B.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Acinetobacter</italic> spp. as nosocomial pathogens: epidemiology and resistance features.</article-title> <source><italic>Saudi J. Biol. Sci.</italic></source> <volume>25</volume> <fpage>586</fpage>&#x2013;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1016/j.sjbs.2016.02.009</pub-id> <pub-id pub-id-type="pmid">29686523</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alikhan</surname> <given-names>N. F.</given-names></name> <name><surname>Petty</surname> <given-names>N. K.</given-names></name> <name><surname>Ben Zakour</surname> <given-names>N. L.</given-names></name> <name><surname>Beatson</surname> <given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons</article-title>. <source><italic>BMC Genomics</italic></source> <volume>12</volume>:<issue>402</issue>. <pub-id pub-id-type="doi">10.1186/1471-2164-12-402</pub-id> <pub-id pub-id-type="pmid">21824423</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blackwell</surname> <given-names>G. A.</given-names></name> <name><surname>Hamidian</surname> <given-names>M.</given-names></name> <name><surname>Hall</surname> <given-names>R. M.</given-names></name></person-group> (<year>2016</year>). <article-title>IncM Plasmid R1215 Is the source of chromosomally located regions containing multiple antibiotic resistance genes in the globally disseminated <italic>Acinetobacter baumannii</italic> GC1 and GC2 Clones.</article-title> <source><italic>mSphere</italic></source> <volume>1</volume>:<fpage>e00117</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/mSphere.00117-16</pub-id> <pub-id pub-id-type="pmid">27303751</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Pirs</surname> <given-names>M.</given-names></name> <name><surname>Seme</surname> <given-names>K.</given-names></name> <name><surname>Schrenzel</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Dissemination of New Delhi metallo-&#x03B2;-lactamase-1-producing <italic>Acinetobacter baumannii</italic> in Europe.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>18</volume> <fpage>E362</fpage>&#x2013;<lpage>E365</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03928.x</pub-id> <pub-id pub-id-type="pmid">22738206</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>New Delhi metallo-&#x03B2;-lactamase-producing <italic>Acinetobacter baumannii</italic>: a novel paradigm for spreading antibiotic resistance genes.</article-title> <source><italic>Future Microbiol.</italic></source> <volume>9</volume> <fpage>33</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.13.69</pub-id> <pub-id pub-id-type="pmid">24328379</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><collab>CLSI</collab> (<year>2020</year>). <source><italic>Performance Standards for Antimicrobial Susceptibility Testing; Thirtieth Informational Supplement. M100-S30.</italic></source> <publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damier-Piolle</surname> <given-names>L.</given-names></name> <name><surname>Magnet</surname> <given-names>S.</given-names></name> <name><surname>Br&#x00E9;mont</surname> <given-names>S.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>52</volume> <fpage>557</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00732-07</pub-id> <pub-id pub-id-type="pmid">18086852</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname> <given-names>E. A.</given-names></name> <name><surname>Coats</surname> <given-names>M. T.</given-names></name> <name><surname>Griffin</surname> <given-names>S.</given-names></name> <name><surname>Pang</surname> <given-names>B.</given-names></name> <name><surname>Briles</surname> <given-names>D. E.</given-names></name> <name><surname>Crain</surname> <given-names>M. J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.</article-title> <source><italic>Pathog. Dis.</italic></source> <volume>76</volume>:<issue>fty073</issue>. <pub-id pub-id-type="doi">10.1093/femspd/fty073</pub-id> <pub-id pub-id-type="pmid">30265307</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Tang</surname> <given-names>M.</given-names></name> <name><surname>Zeng</surname> <given-names>Z.</given-names></name> <name><surname>Song</surname> <given-names>M.</given-names></name> <name><surname>Yang</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>The molecular characteristics, clinical manifestations, and risk factors of hypervirulent <italic>Klebsiella pneumoniae</italic> infections in a large teaching hospital in southwest China.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>162</volume>:<issue>05152</issue>. <pub-id pub-id-type="doi">10.1016/j.micpath.2021.105152</pub-id> <pub-id pub-id-type="pmid">34742892</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donlan</surname> <given-names>R. M.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name></person-group> (<year>2002</year>). <article-title>Biofilms: survival mechanisms of clinically relevant microorganisms.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>15</volume> <fpage>167</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.15.2.167-193.2002</pub-id> <pub-id pub-id-type="pmid">11932229</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dortet</surname> <given-names>L.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Errera</surname> <given-names>C.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>CarbAcineto NP test for rapid detection of carbapenemase-producing <italic>Acinetobacter</italic> spp.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>52</volume> <fpage>2359</fpage>&#x2013;<lpage>2364</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.00594-14</pub-id> <pub-id pub-id-type="pmid">24759709</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>B. A.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>2014</year>). <article-title>OXA &#x03B2;-lactamases.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>27</volume> <fpage>241</fpage>&#x2013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00117-13</pub-id> <pub-id pub-id-type="pmid">24696435</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname> <given-names>S.</given-names></name> <name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Duranteau</surname> <given-names>J.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from <italic>Acinetobacter</italic> haemolyticus. <italic>Acinetobacter johnsonii, and Acinetobacter calcoaceticus</italic>.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>18</volume> <fpage>907</fpage>&#x2013;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03708.x</pub-id> <pub-id pub-id-type="pmid">22128805</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Du</surname> <given-names>X.</given-names></name> <name><surname>Ji</surname> <given-names>J.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii <italic>Acinetobacter</italic> spp. in China.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>67</volume> <fpage>2114</fpage>&#x2013;<lpage>2122</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dks192</pub-id> <pub-id pub-id-type="pmid">22604448</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaddy</surname> <given-names>J. A.</given-names></name> <name><surname>Tomaras</surname> <given-names>A. P.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>The <italic>Acinetobacter baumannii</italic> 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>77</volume> <fpage>3150</fpage>&#x2013;<lpage>3160</lpage>. <pub-id pub-id-type="doi">10.1128/iai.00096-09</pub-id> <pub-id pub-id-type="pmid">19470746</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammerum</surname> <given-names>A. M.</given-names></name> <name><surname>Hansen</surname> <given-names>F.</given-names></name> <name><surname>Littauer</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Use of whole-genome sequencing for characterisation of a ST119 NDM-1-producing <italic>Acinetobacter</italic> pittii from a patient in Denmark with no history of recent travel.</article-title> <source><italic>Int. J. Antimicrob. Agents</italic></source> <volume>46</volume> <fpage>351</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2015.05.005</pub-id> <pub-id pub-id-type="pmid">26143592</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname> <given-names>W.</given-names></name> <name><surname>Wan</surname> <given-names>I.</given-names></name> <name><surname>Jones</surname> <given-names>S. J.</given-names></name> <name><surname>Brinkman</surname> <given-names>F. S.</given-names></name></person-group> (<year>2003</year>). <article-title>IslandPath: aiding detection of genomic islands in prokaryotes</article-title>. <source><italic>Bioinformatics</italic></source> <volume>19</volume>, <fpage>418</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btg004</pub-id> <pub-id pub-id-type="pmid">12584130</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Ruan</surname> <given-names>Z.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name> <name><surname>Ji</surname> <given-names>J.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Prevalence of carbapenem-hydrolyzing class D &#x03B2;-lactamase genes in <italic>Acinetobacter</italic> spp. isolates in China.</article-title> <source><italic>Eur. J. Clin. Microbiol. Infect. Dis.</italic></source> <volume>33</volume> <fpage>989</fpage>&#x2013;<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-013-2037-z</pub-id> <pub-id pub-id-type="pmid">24374815</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>L. S.</given-names></name> <name><surname>Carvalho</surname> <given-names>M. J.</given-names></name> <name><surname>Toleman</surname> <given-names>M. A.</given-names></name> <name><surname>White</surname> <given-names>P. L.</given-names></name> <name><surname>Connor</surname> <given-names>T. R.</given-names></name> <name><surname>Mushtaq</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Characterization of plasmids in extensively drug-resistant <italic>Acinetobacter</italic> strains isolated in India and Pakistan.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>59</volume> <fpage>923</fpage>&#x2013;<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1128/aac.03242-14</pub-id> <pub-id pub-id-type="pmid">25421466</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamolvit</surname> <given-names>W.</given-names></name> <name><surname>Sidjabat</surname> <given-names>H. E.</given-names></name> <name><surname>Paterson</surname> <given-names>D. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Molecular epidemiology and mechanisms of carbapenem resistance of <italic>Acinetobacter</italic> spp. in Asia and Oceania.</article-title> <source><italic>Microb. Drug Resist.</italic></source> <volume>21</volume> <fpage>424</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2014.0234</pub-id> <pub-id pub-id-type="pmid">25714653</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname> <given-names>M. A. F.</given-names></name> <name><surname>Ahmed</surname> <given-names>F. A.</given-names></name> <name><surname>Elkhateeb</surname> <given-names>A. F.</given-names></name> <name><surname>Mahmoud</surname> <given-names>E. E.</given-names></name> <name><surname>Ahmed</surname> <given-names>M. I.</given-names></name> <name><surname>Ahmed</surname> <given-names>R. I.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Virulence characteristics of biofilm-forming <italic>acinetobacter baumannii</italic> in clinical isolates using a <italic>Galleria Mellonella</italic> Model.</article-title> <source><italic>Microorganisms</italic></source> <volume>9</volume>:<issue>2365</issue>. <pub-id pub-id-type="doi">10.3390/microorganisms9112365</pub-id> <pub-id pub-id-type="pmid">34835490</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>M.</given-names></name> <name><surname>Park</surname> <given-names>J.</given-names></name> <name><surname>Park</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Genomic and phenotypic analyses of multidrug-resistant <italic>Acinetobacter baumannii</italic> NCCP 16007 isolated from a patient with a urinary tract infection.</article-title> <source><italic>Virulence</italic></source> <volume>12</volume> <fpage>150</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2020.1867421</pub-id> <pub-id pub-id-type="pmid">33372826</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krahn</surname> <given-names>T.</given-names></name> <name><surname>Wibberg</surname> <given-names>D.</given-names></name> <name><surname>Maus</surname> <given-names>I.</given-names></name> <name><surname>Winkler</surname> <given-names>A.</given-names></name> <name><surname>Bontron</surname> <given-names>S.</given-names></name> <name><surname>Sczyrba</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Intraspecies transfer of the chromosomal <italic>Acinetobacter baumannii</italic> blaNDM-1 Carbapenemase Gene.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>60</volume> <fpage>3032</fpage>&#x2013;<lpage>3040</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00124-16</pub-id> <pub-id pub-id-type="pmid">26953198</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koren</surname> <given-names>S.</given-names></name> <name><surname>Walenz</surname> <given-names>B. P.</given-names></name> <name><surname>Berlin</surname> <given-names>K.</given-names></name> <name><surname>Miller</surname> <given-names>J. R.</given-names></name> <name><surname>Bergman</surname> <given-names>N. H.</given-names></name> <name><surname>Phillippy</surname> <given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res.</article-title> <volume>27</volume>, <fpage>722</fpage>&#x2013;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1101/gr.215087.116</pub-id> <pub-id pub-id-type="pmid">28298431</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S.</given-names></name> <name><surname>Stecher</surname> <given-names>G.</given-names></name> <name><surname>Tamura</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets</article-title>. <source><italic>Mol. Biol. Evol.</italic></source> <volume>33</volume>, <fpage>1870</fpage>&#x2013;<lpage>1874</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msw054</pub-id> <pub-id pub-id-type="pmid">27004904</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labarca</surname> <given-names>J. A.</given-names></name> <name><surname>Salles</surname> <given-names>M. J.</given-names></name> <name><surname>Seas</surname> <given-names>C.</given-names></name> <name><surname>Guzm&#x00E1;n-Blanco</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Carbapenem resistance in <italic>Pseudomonas aeruginosa</italic> and <italic>Acinetobacter baumannii</italic> in the nosocomial setting in Latin America.</article-title> <source><italic>Crit. Rev. Microbiol.</italic></source> <volume>42</volume> <fpage>276</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.3109/1040841x.2014.940494</pub-id> <pub-id pub-id-type="pmid">25159043</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y. T.</given-names></name> <name><surname>Chen</surname> <given-names>H. Y.</given-names></name> <name><surname>Yang</surname> <given-names>Y. S.</given-names></name> <name><surname>Chou</surname> <given-names>Y. C.</given-names></name> <name><surname>Chang</surname> <given-names>T. Y.</given-names></name> <name><surname>Hsu</surname> <given-names>W. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>AdeABC efflux pump controlled by AdeRS two component system conferring resistance to tigecycline, omadacycline and eravacycline in clinical carbapenem resistant <italic>Acinetobacter</italic> nosocomialis.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>11</volume>:<issue>584789</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.584789</pub-id> <pub-id pub-id-type="pmid">33224122</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leus</surname> <given-names>I. V.</given-names></name> <name><surname>Weeks</surname> <given-names>J. W.</given-names></name> <name><surname>Bonifay</surname> <given-names>V.</given-names></name> <name><surname>Smith</surname> <given-names>L.</given-names></name> <name><surname>Richardson</surname> <given-names>S.</given-names></name> <name><surname>Zgurskaya</surname> <given-names>H. I.</given-names></name></person-group> (<year>2018</year>). <article-title>Substrate specificities and efflux efficiencies of RND efflux pumps of <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>200</volume> <fpage>e49</fpage>&#x2013;<lpage>e18</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00049-18</pub-id> <pub-id pub-id-type="pmid">29661860</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Yu</surname> <given-names>T.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Peng</surname> <given-names>J. Y.</given-names></name> <name><surname>Li</surname> <given-names>Y. J.</given-names></name> <name><surname>Tao</surname> <given-names>X. Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Characterization of carbapenem-resistant hypervirulent <italic>Acinetobacter baumannii</italic> strains isolated from hospitalized patients in the mid-south region of China.</article-title> <source><italic>BMC Microbiol.</italic></source> <volume>20</volume>:<issue>281</issue>. <pub-id pub-id-type="doi">10.1186/s12866-020-01957-7</pub-id> <pub-id pub-id-type="pmid">32928115</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Ding</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Jin</surname> <given-names>X.</given-names></name> <name><surname>Xie</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Phenotypic and genotypic characteristics of biofilm formation in clinical isolates of <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Infect. Drug Resist.</italic></source> <volume>14</volume> <fpage>2613</fpage>&#x2013;<lpage>2624</lpage>. <pub-id pub-id-type="doi">10.2147/idr.S310081</pub-id> <pub-id pub-id-type="pmid">34262306</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Feng</surname> <given-names>Y.</given-names></name> <name><surname>Wei</surname> <given-names>L.</given-names></name> <name><surname>Xiao</surname> <given-names>Y.</given-names></name> <name><surname>Zong</surname> <given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>KPC-2-producing carbapenem-resistant <italic>Klebsiella pneumoniae</italic> of the uncommon ST29 type carrying OXA-926, a novel narrow-spectrum OXA &#x03B2;-lactamase.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>12</volume>:<issue>701513</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.701513</pub-id> <pub-id pub-id-type="pmid">34512578</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luca&#x00DF;en</surname> <given-names>K.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>C.</given-names></name> <name><surname>Wille</surname> <given-names>J.</given-names></name> <name><surname>Xanthopoulou</surname> <given-names>K.</given-names></name> <name><surname>Hackel</surname> <given-names>M.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant <italic>Acinetobacter baumannii</italic> from a worldwide survey.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>76</volume> <fpage>1724</fpage>&#x2013;<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkab079</pub-id> <pub-id pub-id-type="pmid">33760099</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montealegre</surname> <given-names>M. C.</given-names></name> <name><surname>Maya</surname> <given-names>J. J.</given-names></name> <name><surname>Correa</surname> <given-names>A.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Mojica</surname> <given-names>M. F.</given-names></name> <name><surname>Ruiz</surname> <given-names>S. J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>First identification of OXA-72 carbapenemase from <italic>Acinetobacter</italic> pittii in Colombia.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>56</volume> <fpage>3996</fpage>&#x2013;<lpage>3998</lpage>. <pub-id pub-id-type="doi">10.1128/aac.05628-11</pub-id> <pub-id pub-id-type="pmid">22508295</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Dortet</surname> <given-names>L.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Carbapenem resistance in <italic>Enterobacteriaceae</italic>: here is the storm!</article-title> <source><italic>Trends Mol. Med.</italic></source> <volume>18</volume> <fpage>263</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2012.03.003</pub-id> <pub-id pub-id-type="pmid">22480775</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pailhori&#x00E8;s</surname> <given-names>H.</given-names></name> <name><surname>Hadjadj</surname> <given-names>L.</given-names></name> <name><surname>Mahieu</surname> <given-names>R.</given-names></name> <name><surname>Crochette</surname> <given-names>N.</given-names></name> <name><surname>Rolain</surname> <given-names>J. M.</given-names></name> <name><surname>Kempf</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Fortuitous diagnosis of NDM-1-producing <italic>Acinetobacter</italic> pittii carriage in a patient from France with no recent history of travel.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>72</volume> <fpage>942</fpage>&#x2013;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkw505</pub-id> <pub-id pub-id-type="pmid">27999060</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname> <given-names>F.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Decker</surname> <given-names>B. K.</given-names></name> <name><surname>Rather</surname> <given-names>P. N.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Global challenge of multidrug-resistant <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>51</volume> <fpage>3471</fpage>&#x2013;<lpage>3484</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01464-06</pub-id> <pub-id pub-id-type="pmid">17646423</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E9;richon</surname> <given-names>B.</given-names></name> <name><surname>Goussard</surname> <given-names>S.</given-names></name> <name><surname>Walewski</surname> <given-names>V.</given-names></name> <name><surname>Krizova</surname> <given-names>L.</given-names></name> <name><surname>Cerqueira</surname> <given-names>G.</given-names></name> <name><surname>Murphy</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Identification of 50 class D &#x03B2;-lactamases and 65 <italic>Acinetobacter</italic>-derived cephalosporinases in <italic>Acinetobacter</italic> spp.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>58</volume> <fpage>936</fpage>&#x2013;<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01261-13</pub-id> <pub-id pub-id-type="pmid">24277043</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Boulanger</surname> <given-names>A.</given-names></name> <name><surname>Schrenzel</surname> <given-names>J.</given-names></name> <name><surname>Kaase</surname> <given-names>M.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Tn125-related acquisition of blaNDM-like genes in <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>56</volume> <fpage>1087</fpage>&#x2013;<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1128/aac.05620-11</pub-id> <pub-id pub-id-type="pmid">22143526</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Figueiredo</surname> <given-names>S.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Acinetobacter</italic> radioresistens as a silent source of carbapenem resistance for <italic>Acinetobacter</italic> spp.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>52</volume> <fpage>1252</fpage>&#x2013;<lpage>1256</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01304-07</pub-id> <pub-id pub-id-type="pmid">18195058</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Principe</surname> <given-names>L.</given-names></name> <name><surname>Piazza</surname> <given-names>A.</given-names></name> <name><surname>Giani</surname> <given-names>T.</given-names></name> <name><surname>Bracco</surname> <given-names>S.</given-names></name> <name><surname>Caltagirone</surname> <given-names>M. S.</given-names></name> <name><surname>Arena</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Epidemic diffusion of OXA-23-producing <italic>Acinetobacter baumannii</italic> isolates in Italy: results of the first cross-sectional countrywide survey.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>52</volume> <fpage>3004</fpage>&#x2013;<lpage>3010</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.00291-14</pub-id> <pub-id pub-id-type="pmid">24920776</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Liang</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<issue>483</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00483</pub-id> <pub-id pub-id-type="pmid">27148178</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Mart&#x00ED;</surname> <given-names>S.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>First identification and characterization of an AdeABC-like efflux pump in <italic>Acinetobacter</italic> genomospecies 13TU.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>55</volume> <fpage>1285</fpage>&#x2013;<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01142-10</pub-id> <pub-id pub-id-type="pmid">21199925</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname> <given-names>D.</given-names></name> <name><surname>Danilchanka</surname> <given-names>O.</given-names></name> <name><surname>Guillard</surname> <given-names>T.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Aschard</surname> <given-names>H.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Fitness cost of antibiotic susceptibility during bacterial infection.</article-title> <source><italic>Sci. Transl. Med.</italic></source> <volume>7</volume>:<issue>297ra114</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aab1621</pub-id> <pub-id pub-id-type="pmid">26203082</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruzin</surname> <given-names>A.</given-names></name> <name><surname>Keeney</surname> <given-names>D.</given-names></name> <name><surname>Bradford</surname> <given-names>P. A.</given-names></name></person-group> (<year>2007</year>). <article-title>AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in <italic>Acinetobacter</italic> calcoaceticus-<italic>Acinetobacter baumannii</italic> complex.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>59</volume> <fpage>1001</fpage>&#x2013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkm058</pub-id> <pub-id pub-id-type="pmid">17363424</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname> <given-names>B.</given-names></name> <name><surname>Ghalavand</surname> <given-names>Z.</given-names></name> <name><surname>Yadegar</surname> <given-names>A.</given-names></name> <name><surname>Eslami</surname> <given-names>G.</given-names></name></person-group> (<year>2021</year>). <article-title>Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Antimicrob. Resist. Infect. Control</italic></source> <volume>10</volume>:<issue>53</issue>. <pub-id pub-id-type="doi">10.1186/s13756-021-00924-9</pub-id> <pub-id pub-id-type="pmid">33691788</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Prokka: rapid prokaryotic genome annotation</article-title>. <source><italic>Bioinformatics</italic></source> <volume>30</volume>, <fpage>2068</fpage>&#x2013;<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id> <pub-id pub-id-type="pmid">24642063</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schleicher</surname> <given-names>X.</given-names></name> <name><surname>Higgins</surname> <given-names>P. G.</given-names></name> <name><surname>Wisplinghoff</surname> <given-names>H.</given-names></name> <name><surname>K&#x00F6;rber-Irrgang</surname> <given-names>B.</given-names></name> <name><surname>Kresken</surname> <given-names>M.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Molecular epidemiology of <italic>Acinetobacter baumannii</italic> and <italic>Acinetobacter</italic> nosocomialis in Germany over a 5-year period (2005-2009).</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>19</volume> <fpage>737</fpage>&#x2013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1111/1469-0691.12026</pub-id> <pub-id pub-id-type="pmid">23034071</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Kan</surname> <given-names>J.</given-names></name> <name><surname>Yin</surname> <given-names>M.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Wan</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Acquired mucoid phenotype of <italic>Acinetobacter baumannii</italic>: impact for the molecular characteristics and virulence.</article-title> <source><italic>Microbiol. Res.</italic></source> <volume>246</volume>:<issue>126702</issue>. <pub-id pub-id-type="doi">10.1016/j.micres.2021.126702</pub-id> <pub-id pub-id-type="pmid">33465557</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname> <given-names>F.</given-names></name> <name><surname>Wilm</surname> <given-names>A.</given-names></name> <name><surname>Dineen</surname> <given-names>D.</given-names></name> <name><surname>Gibson</surname> <given-names>T. J.</given-names></name> <name><surname>Karplus</surname> <given-names>K.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using clustal Omega</article-title>. <source><italic>Mol. Syst. Biol.</italic></source> <volume>7</volume>:<issue>539</issue>. <pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id> <pub-id pub-id-type="pmid">21988835</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singkham-In</surname> <given-names>U.</given-names></name> <name><surname>Chatsuwan</surname> <given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Mechanisms of carbapenem resistance in <italic>Acinetobacter</italic> pittii and <italic>Acinetobacter</italic> nosocomialis isolates from Thailand.</article-title> <source><italic>J. Med. Microbiol.</italic></source> <volume>67</volume> <fpage>1667</fpage>&#x2013;<lpage>1672</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000845</pub-id> <pub-id pub-id-type="pmid">30311872</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>W.</given-names></name> <name><surname>Kumar</surname> <given-names>V.</given-names></name> <name><surname>Ding</surname> <given-names>Y.</given-names></name> <name><surname>Ero</surname> <given-names>R.</given-names></name> <name><surname>Serra</surname> <given-names>A.</given-names></name> <name><surname>Lee</surname> <given-names>B. S. T.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Ribosome protection by antibiotic resistance ATP-binding cassette protein.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A</italic></source> <volume>115</volume> <fpage>5157</fpage>&#x2013;<lpage>5162</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1803313115</pub-id> <pub-id pub-id-type="pmid">29712846</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname> <given-names>J. Y.</given-names></name> <name><surname>Koo</surname> <given-names>S. H.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Kwon</surname> <given-names>G. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Emergence of <italic>Acinetobacter</italic> pittii harboring New Delhi metallo-beta-lactamase genes in Daejeon. Korea.</article-title> <source><italic>Ann. Lab. Med.</italic></source> <volume>35</volume> <fpage>531</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.3343/alm.2015.35.5.531</pub-id> <pub-id pub-id-type="pmid">26206691</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>M.</given-names></name> <name><surname>Wei</surname> <given-names>X.</given-names></name> <name><surname>Wan</surname> <given-names>X.</given-names></name> <name><surname>Ding</surname> <given-names>Z.</given-names></name> <name><surname>Ding</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>The role and relationship with efflux pump of biofilm formation in <italic>Klebsiella pneumoniae</italic>.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>147</volume>:<issue>104244</issue>. <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104244</pub-id> <pub-id pub-id-type="pmid">32437832</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tietgen</surname> <given-names>M.</given-names></name> <name><surname>Leukert</surname> <given-names>L.</given-names></name> <name><surname>Sommer</surname> <given-names>J.</given-names></name> <name><surname>Kramer</surname> <given-names>J. S.</given-names></name> <name><surname>Brunst</surname> <given-names>S.</given-names></name> <name><surname>Wittig</surname> <given-names>I.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Characterization of the novel OXA-213-like &#x03B2;-lactamase OXA-822 from <italic>Acinetobacter</italic> calcoaceticus.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>76</volume> <fpage>626</fpage>&#x2013;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkaa488</pub-id> <pub-id pub-id-type="pmid">33201995</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turton</surname> <given-names>J. F.</given-names></name> <name><surname>Hyde</surname> <given-names>R.</given-names></name> <name><surname>Martin</surname> <given-names>K.</given-names></name> <name><surname>Shah</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Genes encoding OXA-134-like enzymes are found in <italic>Acinetobacter</italic> lwoffii and A. schindleri and can be used for identification.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>50</volume> <fpage>1019</fpage>&#x2013;<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.06173-11</pub-id> <pub-id pub-id-type="pmid">22205817</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turton</surname> <given-names>J. F.</given-names></name> <name><surname>Ward</surname> <given-names>M. E.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Kaufmann</surname> <given-names>M. E.</given-names></name> <name><surname>Pike</surname> <given-names>R.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The role of ISAba1 in expression of OXA carbapenemase genes in <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>FEMS Microbiol. Lett.</italic></source> <volume>258</volume> <fpage>72</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00195.x</pub-id> <pub-id pub-id-type="pmid">16630258</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>V&#x00E1;zquez-Laslop</surname> <given-names>N.</given-names></name> <name><surname>Mankin</surname> <given-names>A. S.</given-names></name></person-group> (<year>2018</year>). <article-title>How macrolide antibiotics work.</article-title> <source><italic>Trends Biochem. Sci.</italic></source> <volume>43</volume> <fpage>668</fpage>&#x2013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2018.06.011</pub-id> <pub-id pub-id-type="pmid">30054232</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vrancianu</surname> <given-names>C. O.</given-names></name> <name><surname>Popa</surname> <given-names>L. I.</given-names></name> <name><surname>Bleotu</surname> <given-names>C.</given-names></name> <name><surname>Chifiriuc</surname> <given-names>M. C.</given-names></name></person-group> (<year>2020</year>). <article-title>Targeting plasmids to limit acquisition and transmission of antimicrobial resistance.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>11</volume>:<issue>761</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.00761</pub-id> <pub-id pub-id-type="pmid">32435238</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>B. S.</given-names></name> <name><surname>Harding</surname> <given-names>C. M.</given-names></name> <name><surname>Feldman</surname> <given-names>M. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Pathogenic <italic>Acinetobacter</italic>: from the cell surface to infinity and beyond.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>198</volume> <fpage>880</fpage>&#x2013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00906-15</pub-id> <pub-id pub-id-type="pmid">26712938</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>D.</given-names></name> <name><surname>Nielsen</surname> <given-names>T. B.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Pantapalangkoor</surname> <given-names>P.</given-names></name> <name><surname>Luna</surname> <given-names>B.</given-names></name> <name><surname>Spellberg</surname> <given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Clinical and pathophysiological overview of <italic>Acinetobacter</italic> infections: a century of challenges.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>30</volume> <fpage>409</fpage>&#x2013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00058-16</pub-id> <pub-id pub-id-type="pmid">27974412</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>T.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Wen</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Cheng</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Resistance of <italic>Klebsiella pneumoniae</italic> strains carrying bla (NDM-1) gene and the genetic environment of bla (NDM-1).</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>11</volume>:<issue>700</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.00700</pub-id> <pub-id pub-id-type="pmid">32425903</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Jia</surname> <given-names>X.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Song</surname> <given-names>Q.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Dissemination and characterization of NDM-1-producing <italic>Acinetobacter</italic> pittii in an intensive care unit in China.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>18</volume> <fpage>E506</fpage>&#x2013;<lpage>E513</lpage>. <pub-id pub-id-type="doi">10.1111/1469-0691.12035</pub-id> <pub-id pub-id-type="pmid">23036089</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>Y. C.</given-names></name> <name><surname>Kiratisin</surname> <given-names>P.</given-names></name> <name><surname>Dowzicky</surname> <given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Antimicrobial activity among gram-positive and gram-negative organisms collected from the Asia-Pacific region as part of the tigecycline evaluation and surveillance trial: comparison of 2015 results with previous years.</article-title> <source><italic>Diagn. Microbiol. Infect. Dis.</italic></source> <volume>89</volume> <fpage>314</fpage>&#x2013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2017.08.014</pub-id> <pub-id pub-id-type="pmid">28951056</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>E. J.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Grillot-Courvalin</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>RND-type efflux pumps in multidrug-resistant clinical isolates of <italic>Acinetobacter baumannii</italic>: major role for AdeABC overexpression and AdeRS mutations.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>57</volume> <fpage>2989</fpage>&#x2013;<lpage>2995</lpage>. <pub-id pub-id-type="doi">10.1128/aac.02556-12</pub-id> <pub-id pub-id-type="pmid">23587960</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>E. J.</given-names></name> <name><surname>Jeong</surname> <given-names>S. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Class D &#x03B2;-lactamases.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>76</volume> <fpage>836</fpage>&#x2013;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkaa513</pub-id> <pub-id pub-id-type="pmid">33382875</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeighami</surname> <given-names>H.</given-names></name> <name><surname>Valadkhani</surname> <given-names>F.</given-names></name> <name><surname>Shapouri</surname> <given-names>R.</given-names></name> <name><surname>Samadi</surname> <given-names>E.</given-names></name> <name><surname>Haghi</surname> <given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>Virulence characteristics of multidrug resistant biofilm forming <italic>Acinetobacter baumannii</italic> isolated from intensive care unit patients.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>19</volume>:<issue>629</issue>. <pub-id pub-id-type="doi">10.1186/s12879-019-4272-0</pub-id> <pub-id pub-id-type="pmid">31315572</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p><ext-link ext-link-type="uri" xlink:href="https://cge.cbs.dtu.dk/services/ResFinder-3.2/">https://cge.cbs.dtu.dk/services/ResFinder-3.2/</ext-link></p></fn>
<fn id="footnote2">
<label>2</label>
<p><ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link></p></fn>
<fn id="footnote3">
<label>3</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.biologicscorp.com/tools/GCContent/#.XnIhjqgzZPY">https://www.biologicscorp.com/tools/GCContent/#.XnIhjqgzZPY</ext-link></p></fn>
<fn id="footnote4">
<label>4</label>
<p><ext-link ext-link-type="uri" xlink:href="https://isfinder.biotoul.fr/blast.php">https://isfinder.biotoul.fr/blast.php</ext-link></p></fn>
<fn id="footnote5">
<label>5</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.mgc.ac.cn/VFs/main.htm">http://www.mgc.ac.cn/VFs/main.htm</ext-link></p></fn>
<fn id="footnote6">
<label>6</label>
<p><ext-link ext-link-type="uri" xlink:href="https://espript.ibcp.fr/ESPript/ESPript/">https://espript.ibcp.fr/ESPript/ESPript/</ext-link></p></fn>
<fn id="footnote7">
<label>7</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.compbio.dundee.ac.uk/jpred/">https://www.compbio.dundee.ac.uk/jpred/</ext-link></p></fn>
<fn id="footnote8">
<label>8</label>
<p><ext-link ext-link-type="uri" xlink:href="http://bldb.eu/BLDB.php?class=D#OXA">http://bldb.eu/BLDB.php?class=D#OXA</ext-link></p></fn>
<fn id="footnote9">
<label>9</label>
<p><ext-link ext-link-type="uri" xlink:href="https://cge.cbs.dtu.dk/services/">https://cge.cbs.dtu.dk/services/</ext-link></p></fn>
</fn-group>
</back>
</article>